bemcentinib
Showing 1 - 6 of 6
Cancer of Pancreas Trial in Dallas (Bemcentinib, Nab-paclitaxel, Gemcitabine)
Terminated
- Cancer of Pancreas
- Bemcentinib
- +3 more
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Sep 26, 2022
NSCLC Trial (Bemcentinib, Pembrolizumab, Pemetrexed)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Bemcentinib
- +3 more
- (no location specified)
Jul 19, 2022
NSCLC Trial in United States (erlotinib, bemcentinib)
Completed
- Non-Small Cell Lung Cancer
- erlotinib
- bemcentinib
-
Los Angeles, California
- +9 more
Aug 16, 2022
Acute Myeloid Leukemia, High-risk Myelodysplastic Syndrome, Low-risk Myelodysplastic Syndrome Trial in France, Germany,
Completed
- Acute Myeloid Leukemia
- +2 more
- Bemcentinib
-
Nantes, Nantes Cedex 1, France
- +7 more
Dec 20, 2021
COVID-19 Trial in India, South Africa (Bemcentinib, SoC)
Completed
- COVID-19
- Bemcentinib
- SoC
-
Surat, Gujarat, India
- +11 more
Oct 13, 2021
Acute Myeloid Leukemia, MDS Trial in Worldwide (Bemcentinib, Cytarabine, Decitabine)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Bemcentinib
- +2 more
-
Iowa City, Iowa
- +11 more
Mar 1, 2022